
<?xml version="1.0" encoding="UTF-8"?>
<TEI xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/joey/Project/grobid/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<encodingDesc>
			<appInfo>
				<application version="0.4.2-SNAPSHOT" ident="GROBID" when="2017-08-10T23:42+0000">
					<ref target="https://github.com/kermitt2/grobid">GROBID - A machine learning software for extracting information from scholarly documents</ref>
				</application>
			</appInfo>
		</encodingDesc>
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Structural bioinformatics Tabhu: tools for antibody humanization</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2015">2015</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName>
								<forename type="first">Pier</forename>
								<forename type="middle">Paolo</forename>
								<surname>Olimpieri</surname>
							</persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Physics</orgName>
								<orgName type="institution">Sapienza University</orgName>
								<address>
									<postCode>00185</postCode>
									<settlement>Rome, Italy</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName>
								<forename type="first">Paolo</forename>
								<surname>Marcatili</surname>
							</persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Physics</orgName>
								<orgName type="institution">Sapienza University</orgName>
								<address>
									<postCode>00185</postCode>
									<settlement>Rome, Italy</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName>
								<forename type="first">Anna</forename>
								<surname>Tramontano</surname>
							</persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Physics</orgName>
								<orgName type="institution">Sapienza University</orgName>
								<address>
									<postCode>00185</postCode>
									<settlement>Rome, Italy</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName>
								<forename type="first">Istituto</forename>
								<surname>Pasteur</surname>
							</persName>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Center for Biological Sequence Analysis</orgName>
								<orgName type="department" key="dep2">Department of Systems Biology</orgName>
								<orgName type="institution">Technical University of Denmark</orgName>
								<address>
									<addrLine>Anker Engelunds Vej 1</addrLine>
									<postCode>2800</postCode>
									<settlement>Lyngby</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName>
								<forename type="first">â€“</forename>
								<surname>Fondazione</surname>
							</persName>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Center for Biological Sequence Analysis</orgName>
								<orgName type="department" key="dep2">Department of Systems Biology</orgName>
								<orgName type="institution">Technical University of Denmark</orgName>
								<address>
									<addrLine>Anker Engelunds Vej 1</addrLine>
									<postCode>2800</postCode>
									<settlement>Lyngby</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName>
								<forename type="first">Cenci</forename>
								<surname>Bolognetti</surname>
							</persName>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Center for Biological Sequence Analysis</orgName>
								<orgName type="department" key="dep2">Department of Systems Biology</orgName>
								<orgName type="institution">Technical University of Denmark</orgName>
								<address>
									<addrLine>Anker Engelunds Vej 1</addrLine>
									<postCode>2800</postCode>
									<settlement>Lyngby</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName>
								<surname>Rome</surname>
							</persName>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Center for Biological Sequence Analysis</orgName>
								<orgName type="department" key="dep2">Department of Systems Biology</orgName>
								<orgName type="institution">Technical University of Denmark</orgName>
								<address>
									<addrLine>Anker Engelunds Vej 1</addrLine>
									<postCode>2800</postCode>
									<settlement>Lyngby</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName>
								<forename type="first">Italy</forename>
								<surname>Associate</surname>
							</persName>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Center for Biological Sequence Analysis</orgName>
								<orgName type="department" key="dep2">Department of Systems Biology</orgName>
								<orgName type="institution">Technical University of Denmark</orgName>
								<address>
									<addrLine>Anker Engelunds Vej 1</addrLine>
									<postCode>2800</postCode>
									<settlement>Lyngby</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName>
								<forename type="first">Alfonso</forename>
								<surname>Valencia</surname>
							</persName>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Center for Biological Sequence Analysis</orgName>
								<orgName type="department" key="dep2">Department of Systems Biology</orgName>
								<orgName type="institution">Technical University of Denmark</orgName>
								<address>
									<addrLine>Anker Engelunds Vej 1</addrLine>
									<postCode>2800</postCode>
									<settlement>Lyngby</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Structural bioinformatics Tabhu: tools for antibody humanization</title>
					</analytic>
					<monogr>
						<imprint>
							<biblScope unit="volume">31</biblScope>
							<biblScope unit="issue">3</biblScope>
							<biblScope unit="page" from="434" to="435"/>
							<date type="published" when="2015">2015</date>
						</imprint>
					</monogr>
					<idno type="DOI">10.1093/bioinformatics/btu667</idno>
					<note type="submission">Received on July 9, 2014; revised on September 9, 2014; accepted on October 6, 2014</note>
					<note>Availability: http://www.biocomputing.it/tabhu Contact: anna.tramontano@uniroma1.it, pierpaolo.olimpieri@uniroma1.it Supplementary information: Supplementary data are available at Bioinformatics online.</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<profileDesc>
			<abstract>
				<p>Antibodies are rapidly becoming essential tools in the clinical practice, given their ability to recognize their cognate antigens with high specificity and affinity, and a high yield at reasonable costs in model animals. Unfortunately, when administered to human patients, xenogeneic antibodies can elicit unwanted and dangerous immuno-genic responses. Antibody humanization methods are designed to produce molecules with a better safety profile still maintaining their ability to bind the antigen. This can be accomplished by grafting the non-human regions determining the antigen specificity into a suitable human template. Unfortunately, this procedure may results in a partial or complete loss of affinity of the grafted molecule that can be restored by back-mutating some of the residues of human origin to the corresponding murine ones. This trial-and-error procedure is hard and involves expensive and time-consuming experiments. Here we present tools for antibody humanization (Tabhu) a web server for antibody humanization. Tabhu includes tools for human template selection, grafting, back-mutation evaluation, antibody modelling and structural analysis, helping the user in all the critical steps of the humanization experiment protocol.</p>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1">INTRODUCTION</head><p>Monoclonal antibodies (mAbs) are an important class of therapeutic molecules. The high specificity and affinity towards their respective antigens, their modular structure that facilitates their engineering and the relative low costs for their production in model animals makes them excellent drug candidates against several diseases (<ref type="bibr" target="#b4">Chames et al., 2009;</ref><ref type="bibr" target="#b14">Reichert, 2012</ref>). However, together with all these desirable characteristics, xenogeneic mAbs have drawbacks that limit their therapeutic benefits and can ultimately endanger the patients' health (<ref type="bibr" target="#b7">Hansel et al., 2010;</ref><ref type="bibr" target="#b8">Hwang and Foote, 2005</ref>). To overcome these hurdles, different methods have been developed for increasing the mAbs 'degree of humanness' (<ref type="bibr" target="#b0">Abhinandan and Martin, 2007</ref>) by replacing parts of the original non-human antibody with the corresponding human counterparts. This process is generally referred as 'humanization' and takes advantage of the particular architecture of the antibody molecule (<ref type="bibr" target="#b1">Almagro and Fransson, 2008;</ref><ref type="bibr" target="#b13">Padlan, 1994</ref>). The molecules generated by such humanization procedures may partially or completely lose affinity for their intended antigen; this can be usually restored by reintroducing specific and case-dependent native residues in the humanized molecule through an experimental trial-and-error procedure going under the name of 'back-mutation' phase. Taking advantage of our experience in antibody sequence and structure analysis (<ref type="bibr" target="#b2">Chailyan et al., 2011;</ref><ref type="bibr" target="#b5">Ghiotto et al., 2011;</ref><ref type="bibr" target="#b11">Marcatili et al., 2013</ref>), we developed Tools for AntiBody Humanization (Tabhu), a comprehensive platform meant to help antibody humanization experiments. Tabhu integrates different methods to guide researchers through several steps of the humanization cycle, from the selection of a suitable human acceptor molecule to the evaluation of the back-mutations effect.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2">DESCRIPTION</head><p>The initial input page of Tabhu requires the sequence of the light and heavy chain variable domains (VL and VH, respectively;<ref type="bibr" target="#b13">Padlan, 1994</ref>) of the xenogeneic antibody to be humanized (native Ab) and the antigen volume since the latter can be used to improve the prediction of the residues involved in antigen recognition (<ref type="bibr" target="#b12">Olimpieri et al., 2013</ref>). Tabhu uses two alternative sources of human sequences to choose the framework donor with the highest sequence similarity to the xenogeneic V region: a database consisting of both light and heavy chain sequences retrieved from the Digit database (<ref type="bibr" target="#b3">Chailyan et al., 2012</ref>) or human germline gene sequences compiled by IMGT (<ref type="bibr" target="#b6">Giudicelli et al., 2005</ref>) from which the user can select the Variable and Joining genes, that are eventually assembled together with the mouse complementarity determining regions (CDRs) to form the initial acceptor molecule. Tabhu lists the possible templates and shows relevant information for each of them. Once a receiving framework has been selected, the server starts an antibody humanization procedure that resembles what is usually done experimentally and involves four steps: (i) loop grafting, (ii) estimate of the binding mode similarity between the native and human antibody, (iii) back-mutations and (iv) reevaluation of the binding mode similarity between input and humanized antibody (Supplementary Material, Supplementary<ref type="figure">Figure S1</ref>). The first step consists of grafting the xenogeneic CDRs into the human framework. The evaluation of the expected similarity *To whom correspondence should be addressed. y The authors wish it to be known that, in their opinion, the first two authors should be regarded as Joint First Authors. ÃŸ The Author 2014. Published by Oxford University Press. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com of the binding mode is based on the proABC method that we have previously developed (<ref type="bibr" target="#b12">Olimpieri et al., 2013</ref>), that predicts the probability that every single antibody residue is involved in antigen recognition taking into account the entire sequence of the variable domains. If the pattern of interaction is very different between the input and humanized sequence, it can be expected that the resulting binding mode, and most likely the affinity, will be different. More details on the formula used to evaluate individual back-mutation importance are reported as Supplementary Material. Once the user selects which residues to back-mutate and submits them to the system, a new variant is generated and the process can be repeated. However, the introduction of mutations in the human antibody can lead to structural problems, such as the appearance of clashes or cavities in the modelled humanized antibody. Taking advantage of our antibody structure prediction tools (<ref type="bibr" target="#b2">Chailyan et al., 2011;</ref><ref type="bibr" target="#b10">Marcatili et al., 2008</ref>), upon user request, Tabhu builds the three-dimensional models of the mouse and humanized antibodies, runs the procheck and EDTSurf tools (<ref type="bibr" target="#b9">Laskowski et al., 1996;</ref><ref type="bibr" target="#b15">Xu and Zhang, 2009</ref>) and alerts the user if the introduction of a back-mutation generates clashes or cavities, that the user can ignore or use as a guide to remove or introduce additional back-mutations. When the desired binding mode similarity between the xenogeneic and humanized antibody has been achieved the user can finalize the model and retrieve the three-dimensional model of the parental antibody, the amino acid sequence of the selected human template, the contact probabilities of the humanized antibody, the amino acid sequence of the final redesigned antibody and a back-translated nucleotide sequence optimized for being expressed in a number of organisms. Supplementary Material, Supplementary File S1 reports an example of antibody humanization with Tabhu.</p></div>
			<note place="foot">at :: on August 30, 2016 http://bioinformatics.oxfordjournals.org/ Downloaded from</note>

			<note place="foot">Tabhu: tools for antibody humanization at :: on August 30, 2016 http://bioinformatics.oxfordjournals.org/ Downloaded from</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ACKNOWLEDGEMENTS</head><p>The authors are grateful to Daniel D'Andrea and all other members of the " Sapienza " Biocomputing unit for useful discussion and for testing the server.</p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct   xml:id="b0">
	<analytic>
		<title level="a" type="main">Analyzing the &quot; degree of humanness &quot; of antibody sequences</title>
		<author>
			<persName>
				<forename type="first">K</forename>
				<forename type="middle">R</forename>
				<surname>Abhinandan</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">A</forename>
				<forename type="middle">C</forename>
				<surname>Martin</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Mol. Biol</title>
		<imprint>
			<biblScope unit="volume">369</biblScope>
			<biblScope unit="page" from="852" to="862" />
			<date type="published" when="2007" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b1">
	<analytic>
		<title level="a" type="main">Humanization of antibodies</title>
		<author>
			<persName>
				<forename type="first">J</forename>
				<forename type="middle">C</forename>
				<surname>Almagro</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">J</forename>
				<surname>Fransson</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Front. Biosci. J. Virtual Libr</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="1619" to="1633" />
			<date type="published" when="2008" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b2">
	<analytic>
		<title level="a" type="main">Structural repertoire of immunoglobulin lambda light chains</title>
		<author>
			<persName>
				<forename type="first">A</forename>
				<surname>Chailyan</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proteins</title>
		<imprint>
			<biblScope unit="volume">79</biblScope>
			<biblScope unit="page" from="1513" to="1524" />
			<date type="published" when="2011" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b3">
	<analytic>
		<title level="a" type="main">A database of immunoglobulins with integrated tools: DIGIT</title>
		<author>
			<persName>
				<forename type="first">A</forename>
				<surname>Chailyan</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="1230" to="1234" />
			<date type="published" when="2012" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b4">
	<analytic>
		<title level="a" type="main">Therapeutic antibodies: successes, limitations and hopes for the future</title>
		<author>
			<persName>
				<forename type="first">P</forename>
				<surname>Chames</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br. J. Pharmacol</title>
		<imprint>
			<biblScope unit="volume">157</biblScope>
			<biblScope unit="page" from="220" to="233" />
			<date type="published" when="2009" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b5">
	<analytic>
		<title level="a" type="main">Mutation pattern of paired immunoglobulin heavy and light variable domains in chronic lymphocytic leukemia B cells</title>
		<author>
			<persName>
				<forename type="first">F</forename>
				<surname>Ghiotto</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Med</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="1188" to="1195" />
			<date type="published" when="2011" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b6">
	<analytic>
		<title level="a" type="main">IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes</title>
		<author>
			<persName>
				<forename type="first">V</forename>
				<surname>Giudicelli</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="256" to="261" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b7">
	<analytic>
		<title level="a" type="main">The safety and side effects of monoclonal antibodies</title>
		<author>
			<persName>
				<forename type="first">T</forename>
				<forename type="middle">T</forename>
				<surname>Hansel</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Rev. Drug Discov</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="325" to="338" />
			<date type="published" when="2010" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b8">
	<analytic>
		<title level="a" type="main">Immunogenicity of engineered antibodies</title>
		<author>
			<persName>
				<forename type="first">W</forename>
				<forename type="middle">Y</forename>
				<surname>Hwang</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">J</forename>
				<surname>Foote</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Methods</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="3" to="10" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b9">
	<analytic>
		<title level="a" type="main">AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR</title>
		<author>
			<persName>
				<forename type="first">R</forename>
				<forename type="middle">A</forename>
				<surname>Laskowski</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biomol. NMR</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="477" to="486" />
			<date type="published" when="1996" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b10">
	<analytic>
		<title level="a" type="main">PIGS: automatic prediction of antibody structures</title>
		<author>
			<persName>
				<forename type="first">P</forename>
				<surname>Marcatili</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="1953" to="1954" />
			<date type="published" when="2008" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b11">
	<analytic>
		<title level="a" type="main">Igs expressed by chronic lymphocytic leukemia B cells show limited binding-site structure variability</title>
		<author>
			<persName>
				<forename type="first">P</forename>
				<surname>Marcatili</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Immunol</title>
		<imprint>
			<biblScope unit="volume">190</biblScope>
			<biblScope unit="page" from="5771" to="5778" />
			<date type="published" when="2013" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b12">
	<analytic>
		<title level="a" type="main">Prediction of site-specific interactions in antibodyantigen complexes: the proABC method and server</title>
		<author>
			<persName>
				<forename type="first">P</forename>
				<forename type="middle">P</forename>
				<surname>Olimpieri</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="2285" to="2291" />
			<date type="published" when="2013" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b13">
	<analytic>
		<title level="a" type="main">Anatomy of the antibody molecule</title>
		<author>
			<persName>
				<forename type="first">E</forename>
				<forename type="middle">A</forename>
				<surname>Padlan</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Immunol</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="169" to="217" />
			<date type="published" when="1994" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b14">
	<analytic>
		<title level="a" type="main">Marketed therapeutic antibodies compendium</title>
		<author>
			<persName>
				<forename type="first">J</forename>
				<forename type="middle">M</forename>
				<surname>Reichert</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">MAbs</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="413" to="415" />
			<date type="published" when="2012" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b15">
	<analytic>
		<title level="a" type="main">Generating triangulated macromolecular surfaces by Euclidean distance transform</title>
		<author>
			<persName>
				<forename type="first">D</forename>
				<surname>Xu</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">Y</forename>
				<surname>Zhang</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<date type="published" when="2009" />
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>